GEOGRAPHIC ATROPHY
Clinical trials for GEOGRAPHIC ATROPHY explained in plain language.
Never miss a new study
Get alerted when new GEOGRAPHIC ATROPHY trials appear
Sign up with your email to follow new studies for GEOGRAPHIC ATROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Own blood used in experimental eye treatment to halt blinding disease
Disease control CompletedThis small study tested whether injections of a patient's own concentrated blood plasma (platelet-rich plasma or PRP) could slow the progression of advanced dry age-related macular degeneration (AMD), a leading cause of vision loss. In 14 participants, one eye received three PRP …
Matched conditions: GEOGRAPHIC ATROPHY
Phase: NA • Sponsor: Marmara University Pendik Training and Research Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New eye injection aims to halt blinding disease in seniors
Disease control CompletedThis study tested whether an experimental injection into the eye (called JNJ-81201887) could slow the progression of geographic atrophy, a late-stage form of age-related macular degeneration that causes permanent vision loss. It involved 305 participants who received either the r…
Matched conditions: GEOGRAPHIC ATROPHY
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New pill aims to slow blinding eye disease
Disease control CompletedThis study tested whether a daily capsule called ALK-001 could slow the progression of geographic atrophy, a severe form of age-related macular degeneration that causes permanent vision loss. About 300 people with this condition were randomly assigned to receive either the study …
Matched conditions: GEOGRAPHIC ATROPHY
Phase: PHASE2, PHASE3 • Sponsor: Alkeus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Researchers track Long-Term safety of promising eye disease treatment
Disease control CompletedThis study followed patients who had already completed a previous trial to check the long-term safety of avacincaptad pegol, an eye injection for geographic atrophy. Geographic atrophy is an advanced form of age-related macular degeneration that causes permanent vision loss. The …
Matched conditions: GEOGRAPHIC ATROPHY
Phase: PHASE3 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
Breakthrough eye injection shows promise in slowing blinding disease
Disease control CompletedThis study tested whether a monthly injection into the eye, called avacincaptad pegol (Zimura), could safely slow the progression of geographic atrophy. Geographic atrophy is a severe form of age-related macular degeneration that causes permanent, progressive vision loss. The tri…
Matched conditions: GEOGRAPHIC ATROPHY
Phase: PHASE3 • Sponsor: IVERIC bio, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Researchers dig into old eye scans to predict blindness risk
Knowledge-focused CompletedThis study looked back at existing medical records and eye scans from 60 patients with geographic atrophy, a severe form of dry macular degeneration that causes vision loss. The goal was to understand which specific features of the retina seen on scans are linked to faster vision…
Matched conditions: GEOGRAPHIC ATROPHY
Sponsor: IRCCS Ospedale San Raffaele • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC